← All organizations
Highest phase reached
Phase 4
First clinical trial
Nov 1, 2002Last known activity
Jun 26, 2023
Timeline
1860s
- Jan 1, 1861
Massachusetts Institute of Technology— Founded
Drugs by trial phase (21 distinct, 19 trials)
Phase 4 (5 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (5 own, 0 via acquisition)
Phase 1 (6 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Indications
Studied for
- Attention Deficit Disorder with Hyperactivity
- Autism Spectrum Disorder
- Autistic Disorder
- Child Development Disorders, Pervasive
- Compartment Syndromes
- Coronavirus Infections
- Crohn Disease
- Disease
- Hyperkinesis
- Marijuana Abuse
- Mental Disorders
- Motion Sickness
- Psychotic Disorders
- Recurrence
- Schizophrenia
- Space Motion Sickness
- Syndrome
- Virus Diseases
- Zika Virus Infection
Recent trials (21)
- NCT05880849CollaboratorPhase 1Jun 26, 2023
- NCT05683223Overall official - principal investigatorN/AJun 1, 2023
- NCT05683223CollaboratorN/AJun 1, 2023
- NCT05649059Lead sponsorPhase 4Jan 31, 2023
- NCT05649059Overall official - principal investigatorPhase 4Jan 31, 2023
- NCT05232032CollaboratorPhase 2Dec 1, 2022
- NCT05034536CollaboratorPhase 2Jan 31, 2022
- NCT04649515Lead sponsorPhase 3Dec 4, 2020
- NCT04429529Lead sponsorPhase 1Jun 9, 2020
- NCT04113954CollaboratorPhase 1Jan 1, 2020
- NCT04027361CollaboratorPhase 2Dec 31, 2019
- NCT03776695Lead sponsorPhase 1Oct 9, 2018
- NCT03538431CollaboratorPhase 4Sep 15, 2018
- NCT03443830Lead sponsorPhase 1Feb 8, 2018
- NCT03153488CollaboratorPhase 4Jul 1, 2017
Details
- Founded
- Cambridge, MA, US Jan 1, 1861
- Last known activity
- Jun 26, 2023